Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-17

Clinical Trial Update: HCG (Human Chorionic Gonadotropin) Priming for Thin Endometrium in IVF (in Vitro Fertilization) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating human chorionic gonadotropin priming to improve thin endometrium in IVF; current status is not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • human chorionic gonadotropin (hCG) (human chorionic gonadotropin)

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Endometrial Thickness, Pregnancy Outcome | Phase 4 | Status: UNKNOWN